Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
7TM Pharma
company
About
7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, asthma, and more.
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $15M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2000
- Operating Status
- Active
7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, gastrointestinal, metabolic, asthma, and vascular diseases. The company offers seven transmembrane-spanning receptors, including TM38837, a small molecule CB1 receptor antagonist; TM30339, a NPY Y4 selective agonist that is used within gastrointestinal disorders, and short bowel syndrome; and CRTH2 antagonist, an oral drug for inflammatory or respiratory diseases.7TM Pharma was founded in 2000 and is based in Lyngby, Hovedstaden.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$37M €25M
7TM Pharma has raised a total of
$37M €25M
in funding over 2 rounds. Their latest funding was raised on
Jun 12, 2007 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 12, 2007 | Series D | $22M | 1 | — | — | Detail |
| Mar 31, 2006 | Series C | €19M | 1 | — | — | Detail |
| Oct 28, 2004 | Series B | €6M | 1 | — | — | Detail |
| Sep 27, 2001 | Series A | $15M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
7TM Pharma is funded by 2 investors.
Dansk Innovation
and LODH Immunology Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
